APA (7th ed.) Citation

Xu-Monette, Z. Y., Li, L., Byrd, J. C., Jabbar, K. J., Manyam, G. C., Maria de Winde, C., . . . Young, K. H. (2016). Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. Blood, 128(26), 3083-3100. https://doi.org/10.1182/blood-2016-05-715094

Chicago Style (17th ed.) Citation

Xu-Monette, Zijun Y., et al. "Assessment of CD37 B-cell Antigen and Cell of Origin Significantly Improves Risk Prediction in Diffuse Large B-cell Lymphoma." Blood 128, no. 26 (2016): 3083-3100. https://doi.org/10.1182/blood-2016-05-715094.

MLA (9th ed.) Citation

Xu-Monette, Zijun Y., et al. "Assessment of CD37 B-cell Antigen and Cell of Origin Significantly Improves Risk Prediction in Diffuse Large B-cell Lymphoma." Blood, vol. 128, no. 26, 2016, pp. 3083-3100, https://doi.org/10.1182/blood-2016-05-715094.